Skip to main content

Advertisement

ADVERTISEMENT

Department

News Connection
12/22/2022
News Connection features the latest industry updates from the November/December 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the November/December 2022 issue of First Report Managed Care.
News Connection features the...
12/22/2022
First Report Managed Care
News Connection
09/23/2022
News Connection features the latest industry updates from the September/October 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the September/October 2022 issue of First Report Managed Care.
News Connection features the...
09/23/2022
First Report Managed Care

Advertisement

News Connection
08/02/2022
News Connection features the latest industry updates from the July/August 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the July/August 2022 issue of First Report Managed Care.
News Connection features the...
08/02/2022
First Report Managed Care
Interview
04/18/2022
Samantha Matthews
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert...
04/18/2022
First Report Managed Care
Conference Insider
03/15/2022
Edan Stanley
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent...
03/15/2022
First Report Managed Care

Advertisement

Conference Insider
03/15/2022
Samantha Matthews
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults,...
03/15/2022
First Report Managed Care
Conference Insider
03/15/2022
Maria Asimopoulos
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are...
03/15/2022
First Report Managed Care
News Connection
02/07/2022
News Connection features the latest industry updates from the January/February 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the January/February 2022 issue of First Report Managed Care.
News Connection features the...
02/07/2022
First Report Managed Care

Advertisement

Veterans Health Today
01/28/2022
Paul Nicolaus
A new study examines the possibility of increasing physical activity among veterans by turning daily step counts into a game.
A new study examines the possibility of increasing physical activity among veterans by turning daily step counts into a game.
A new study examines the...
01/28/2022
First Report Managed Care
Conference Insider
11/22/2021
Maria Asimopoulos
At AMCP Nexus 2021, Jason Borschow, founder and CEO, Abarca, explained the rationale behind Assura, a new product that will make the pharmacy benefit manager accountable for changes in list prices and increase drug spending transparency for...
At AMCP Nexus 2021, Jason Borschow, founder and CEO, Abarca, explained the rationale behind Assura, a new product that will make the pharmacy benefit manager accountable for changes in list prices and increase drug spending transparency for...
At AMCP Nexus 2021, Jason...
11/22/2021
First Report Managed Care

Advertisement